8
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Propranolol-Induced Depression

Mechanism and Management

Pages 400-402 | Published online: 19 Jan 2011

References

  • Charney D. S., Menkes D. B., Heninger G. R. Receptor sensitivity and the mechanism of action of antidepressant treatment. Archives of General Psychiatry 1981; 38: 1160–1180
  • Cruickshank J. M. The clinical importance of cardioselectivity and lipophilicity in beta blockers. American Heart Journal 1980; 100: 160–178
  • Fitzgerald J. D. Perspectives in adrenergic beta-receptor blockade. Clinical Pharmacology and Therapeutics 1967; 10: 297–306
  • Frazer H. S., Carr A. C. Propranolol psychosis. British Journal of Psychiatry 1976; 129: 508–509
  • Glaubiger G., Lefkowitz R. J. Elevated beta adrenergic receptor number after chronic propranolol treatment. Biochemical and Biophysical Research Communications 1977; 78: 720–725
  • Henningsen N. C., Mattiasson I. Long-term clinical experience with atenolol—a new selective beta-l-blocker with few side-effects from the central nervous system. Acta Medica Scandinavica 1979; 205: 61–66
  • Kline N. S. Incidence, prevalence and recognition of depressive illness. Diseases of the Nervous System 1976; 37: 10–14
  • Lecrubier Y., Puech A. J., Jouvent R., Simon P., Widlocher D. A beta adrenergic stimulant (salbutamol) versus clomipramine in depression: a controlled study. British Journal of Psychiatry 1980; 136: 354–358
  • Lerer B., Ebstein R. P., Belmaker R. H. Subsensitivity of human beta adrenergic adenylate cyclase after salbutamol treatment of depression. Psychopharmacology 1981; 75: 169–172
  • Maas J. W., Huang Y. Noradrenergic function and depression, too much or too little?. Le Journal Canadien des Sciences Neurologiques 1980; 7: 267–268
  • McNeil G. N., Shaw P. K., Dock D. S. Substitution of atenolol for propranolol in a case of propranolol-related depression. American Journal of Psychiatry 1982; 139: 1187–1188
  • Nielsen A. C., Williams T. A. Depression in ambulatory medical patients: prevalence by self-report questionnaire and recognition by non-psychiatric physicians. Archives of General Psychiatry 1980; 37: 999–1004
  • Petrie W. M., Maffucci R. J., Woosley R. L. Propranolol and depression. American Journal of Psychiatry 1982; 139: 92–93
  • Schildkraut J. J. The catecholamine hypothesis of affective disorders: a review of supporting evidence. American Journal of Psychiatry 1965; 122: 509–522
  • Segal D. S., Kuczenski R. T., Mandell A. J. Theoretical implications of drug-induced adaptive regulation for a biogenic amine hypothesis of affective disorder. Biological Psychiatry 1974; 9: 147–159
  • Sullivan J. L., Segal D. S., Kuczenski R. T., Mandell A. J. Propranolol-induced rapid activation of rat striatal tyrosine hydroxylase concomitant with behavioural depression. Biological Psychiatry 1972; 4: 193–203
  • Van Zwieten P. A., Timmermans P. B. Comparison between the acute haemodynamic effects and brain penetration of atenolol and metoprolol. Journal of Cardiovascular Pharmacology 1979; 1: 85–96
  • Waal H. J. Propranolol-induced depression. British Medical Journal 1967; 2: 50

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.